A Qualitative Study of Barriers and Facilitators of PrEP Uptake Among Women in Substance Use Treatment and Syringe Service Programs

被引:0
作者
Susan Tross
Anya Y. Spector
Melissa M. Ertl
Hayley Berg
Eva Turrigiano
Susie Hoffman
机构
[1] Columbia University Irving Medical Center,HIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute
[2] City University of New York,Department of Human Services, Stella and Charles Guttman Community College
[3] Albert Einstein College of Medicine,Department of Epidemiology
[4] New York State Psychiatric Institute,undefined
[5] Columbia University Mailman School of Public Health,undefined
来源
AIDS and Behavior | 2023年 / 27卷
关键词
Pre-exposure prophylaxis (PrEP); HIV prevention; women; implementation;
D O I
暂无
中图分类号
学科分类号
摘要
PrEP is an HIV prevention option that could benefit substance-involved women, a high-risk population with low PrEP uptake. Little is known about their interest in PrEP. This qualitative study used in-depth interviews to examine PrEP willingness, barriers, and facilitators among 16 women in outpatient psychosocial substance use treatment, methadone, and/or harm reduction/syringe programs in NYC. All expressed willingness to use PrEP, but only during periods of perceived risk. Women perceived themselves to be at high risk for HIV when engaging in active substance use and/or transactional sex. They perceived themselves to be at low risk and therefore unmotivated to take PrEP when abstinent from these activities. Paradoxically, a major barrier to using PrEP was anticipated interference from substance use and transactional sex, the very same activities that create a perception of risk. Facilitators of PrEP use included perceptions of it as effortless (as opposed to barrier methods during sex) and effective, safe, and accessible. Other barriers included fear of stigma and doubts about adhering daily. Recommendations for best PrEP implementation practices for substance-involved women included tailored and venue-specific PrEP information and messaging, PrEP discussion with trusted medical providers, and on-site PrEP prescription in substance use treatment and harm reduction programs.
引用
收藏
页码:1162 / 1172
页数:10
相关论文
共 83 条
  • [1] Spinner CD(2016)HIV pre-exposure prophylaxis (PrEP): A review of current knowledge of oral systemic HIV PrEP in humans Infection 44 151-8
  • [2] Boesecke C(2018)The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United States Ann Epidemiol 28 841-9
  • [3] Zink A(2017)Female and younger subjects have lower adherence in PrEP trials: a meta-analysis with implications for the uptake of PrEP service to prevent HIV Sex Transm Infect 94 163-8
  • [4] Siegler AJ(2019)Suboptimal HIV pre-exposure prophylaxis awareness and willingness to use among women who use drugs in the United States: A systematic review and meta-analysis AIDS Behav 23 2641-53
  • [5] Mouhanna F(2015)Theoretical foundations of research focused on HIV prevention among substance-involved women: A review of observational and intervention studies J Acquir Immune Defic Syndr 69 146-54
  • [6] Giler RM(2010)HIV and women who use drugs: Double neglect, double risk Lancet 376 312-4
  • [7] Yun K(2009)Substance use, childhood sexual abuse, and sexual risk behavior among women in methadone treatment Am J Drug Alcohol Abuse 35 305-10
  • [8] Xu J-J(2014)Prevalence and correlates of transactional sex among an urban emergency department sample: Exploring substance use and HIV risk Psychol Addict Behav 28 625-30
  • [9] Zhang J(2019)Alcohol use patterns and subsequent sexual behaviors among women, men who have sex with men and men who have sex with women engaged in routine HIV care in the United States AIDS Behav 23 1634-46
  • [10] Zhang C(2015)Gender-specific HIV prevention interventions for women who use alcohol and other drugs: The evolution of the science and future directions J Acquir Immune Defic Syndr 69 128-39-55